Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

VBH

Interactive infographic

Living With: The journey from the patient’s perspective

Research Partnership

Article: Spotlight on Mexico

Healthcare under AMLO – One year on

Research Partnership

- PMLiVE

Ex-Sandoz exec admits role in generic drug price-fixing plot

Reignites criticism of high drug prices in the US

Novartis day

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

New drug due for launch in Europe in the second quarter

- PMLiVE

Weirdos and misfits

Can diversity improve engagement in healthcare?

- PMLiVE

This isn’t goodbye, it’s see you in August!

Bedrock Group imagines, creates and delivers industry-leading benefits

Bedrock Healthcare Communications

- PMLiVE

Novartis plans inclisiran trial in the UK

Swiss pharma also officially opens new London headquarters

Novartis day

Novartis pulls ahead of Merck in MET-positive lung cancer race

FDA starts priority review of Swiss pharma's MET inhibitor

- PMLiVE

Novartis faces criticism over Zolgensma ‘health lottery’

SMA Europe deems access programme 'inappropriate'

Onyx Health Launch ‘Game-changing’ New Digital Offer

Onyx Health have recently launched a new digital offering to bridge the digital skills gap in the pharma and healthcare sectors

Onyx Health

- PMLiVE

Four Comms restructures, reveals 2019 revenue growth and acquisition plan

Four Communications has undergone a restructure, with 17 practices reorganised into seven business units - as the firm reveals that revenue grew eight per cent in 2019. It is also...

Four Health

Novartis day

Cosentyx, Entresto drive topline growth for Novartis in Q4

Overall net income fell for the full year compared to 2018

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links